MUMBAI, India, Jan. 9 -- Intellectual Property India has published a patent application (202511113240 A) filed by Swami Vivekanand Subharti University, Ghaziabad, Uttar Pradesh, on Nov. 18, 2025, for 'zavegepant-containing transdermal therapeutic system for chronic migraine treatment.'
Inventor(s) include Dr. Kunal Arora; and Dr. Sumita Singh.
The application for the patent was published on Jan. 9, under issue no. 02/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to a transdermal patch formulation comprising Zavegepant, a calcitonin gene-related peptide (CGRP) receptor antagonist, for the treatment and management of chronic migraine. The patch delivers Zavegepant in a controlle...